Dr.Prashant Jani
  Research and Publications
 

Please visit www.oncopathology.blogspot.ca

PUBLICATIONS AND PRESENTATIONS
 

1)    D-240 expression on luminal surface of pulmonary   airspaces in normal developing and adult lung but is lost in conditions associated with intra alveolar infiltrates.

  • Presentation at Unites states and Canadian Academy of Pathology,2005, San Antanio, USA

 

2)   Aberrant expression of CD4 and CD7 T cell antigens in   Atypical B cell –

      Chronic  Lymphocytic leukemia.

  • Presentation at American Society of Clinical Pathology, Nov.2005, Chicago, USA.
  • Prashant Jani,Abdel Walkett and Hong Chang,Am J Hematol.2007 Jan;82(1):73-6.

 

3)   CD 138 expression in Merkel cell carcinoma: A potential diagnostic pitfall in hematological malignancies.

  • Presentation at  Annual meeting of Canadian Association of Pathologist,

       June, 2006, Toronto, Ontario, Canada.

 

4)   Synchronous adrenocrtical and renal cell carcinoma: A rare association

  • Presentation at annual meeting of Canadian Association of Pathologist, June, 2006, Toronto, Ontario, Canada.
  • Prashant Jani, D.El-demallawy, The Canadian Journal of Urology, 2007 Jan;56(11):933-50.

 

5)   Value of CD 138 in normal and Pathological endometrium

  • Poster presentation at  Annual meeting of Canadian Association of Pathologist,

     June, 2006, Toronto, Ontario, Canada.

 

6)   Application of immunohistochemistry in classification of ovarian tumors

  • Poster presentation at American Society of Clinical pathology,Oct.2004 San Antonio, USA

 

7) An approach to duodenal biopsies. Review article.

  • S.Serra, P.Jani J Clin Pathol. 2006 Nov;59(11):1133-50. 2006

8)   Massive Bone Marrow Involvement by Alveolar Rhabdomyosarcoma with an

      Unusual Histologic Pattern and an Unknown Primary Site: A case Report with  

      Morphologic, Immunohistochemical, Ultrastructural, and Cytogenetic Studies

  • Prashant Jani, Charles Ye, Nov.2007,Journal of Clinical pathology.

 

9) An unusual composite pilomatrix carcinoma with intralesional melanocytes: differential

    diagnosis, immunohistochemical evaluation, and review of the literature. Jani Prashant; Chetty Runjan; Ghazarian Danny M.  The American Journal of dermatopathology  2008;30(2):174-7.

 

10) Comparative analysis of CD 56, calretinin, and inhibin immunohistochemical staining in the diagnosis of ovarian granulosa cell tumors. 

  • Poster presentation-Unites states and Canadian Academyof Pathology, 2008,  Denver,USA

 

11)  Prognostic Relevance of 6q Deletion in Waldenström Macroglobulinemia: A Multi-Center Study ; Clinical Lymphoma & Myeloma March 2009

 

12 ) Long-term Outcomes of Hypofractionation Versus Conventional Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ of the Breast International journal of radiation oncology, biology, physics (Impact Factor: 4.59). 01/2014; DOI: 10.1016/j.ijrobp.2014.07.026

 

13) Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis. Current Oncology (Impact Factor: 1.63). 02/2014; 21(1):e96-e104. DOI: 10.3747/co.21.1604

 

14) Impact of Boost Radiation in the Treatment of Ductal Carcinoma In Situ: A Population-Based Analysis. International journal of radiation oncology, biology, physics (Impact Factor: 4.59). 07/2013; 86(3):491-497. DOI: 10.1016/j.ijrobp.2013.02.031

 

 

15) Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Research and Treatment (Impact Factor: 4.47). 03/2013; DOI: 10.1007/s10549-013-2455-8

 
  Today, there have been 15 visitors (28 hits) on this page!  
 
=> Do you also want a homepage for free? Then click here! <=